R
etinal pigment epithelial (RPE) cells form a barrier epithelium between the neural retina and the choriocapillaris at the back of the eye. They play an important role in the bloodretinal barrier and control access of nutrients from the choroidal blood supply to the outer retina. RPE cells have many other functions, including reduction of light scattering, participation in the visual cycle, the removal of waste products (including shed outer segment membranes), and the maintenance of the interphotoreceptor ionic environment. 1 RPE cells do not usually divide in adult life, but in certain diseases, such as proliferative vitreoretinopathy (PVR), they can dissociate from the Bruch's membrane and proliferate in the vitreous or in the subretinal space. [2] [3] [4] In PVR, RPE cells are found in epiretinal membranes, which contain various cell types embedded in an extracellular matrix distinct from that of the vitreous. In what can be regarded as an aberrant wound-healing response, 2, 3 these membranes become contractile and cause traction retinal detachment and loss of sight. RPE cells are thought to play a critical role in the formation and contraction of these membranes. 5 The RPE cells in PVR membranes have often undergone morphologic changes and appear more fibroblast-like than epithelial. 4 When exposed to vitreous in vivo 6 or in vitro, 7 they undergo similar morphologic changes. In vitro, this epithelial-mesenchymal transformation (EMT)-like process requires the presence of serum factors as well as vitreous. 8 Risk factors for PVR include the presence of RPE cells in the vitreous, a tear in the neural retina (which could expose the RPE layer to vitreous components), a breakdown in the blood-retinal barrier and the presence of inflammatory components. 3,9 -11 Knowledge of which mRNAs are modulated by vitreous treatment of RPE cells will help elucidate the early stages of PVR. Thus, differential display polymerase chain reaction (PCR)-based methods 12, 13 and membrane arrays representing 588 genes 14 have been used, but these studies identified only a limited number of gene changes at a single time point. We report here the use of 21,000-gene microarrays to profile vitreous-induced changes in gene expression in low-passage human RPE cells from multiple donors at various times of treatment. Since vitreous-induced transformation of RPE cells requires serum, 8 all these experiments were performed in the presence of serum. Vitreous caused a progressive change in the transcriptional program of these cells. There was a downregulation of genes associated with tight junctions and a change in expression of focal adhesion genes, as would be expected if epithelial cells lost cell-cell contact, became migratory, and transformed into more fibroblast-like cells. Many of the modulated genes were associated with the transforming growth factor-␤ (TGF␤)/bone morphogenetic protein (BMP) pathway.
METHODS

RPE Cells
RPE cells were obtained postmortem from human donor eyes (Lifepoint, Charleston, SC, and Lions' Eye Bank, Portland, OR). The protocol adhered to the tenets of the Declaration of Helsinki for research involving human tissue. Eyes were not used if there was a known history of retinal disease or diabetes. RPE cells were isolated as described previously 15 and cultured in F-10 medium (Invitrogen Corp., Carlsbad, CA) containing 10% fetal bovine serum (Invitrogen Corp.), 1% penicillin-streptomycin-glutamine (Invitrogen Corp.), 1 M CaCl 2 , and 1% ITS (BD Biosciences, Franklin Lakes, CA). The epithelioid nature of the RPE cells was checked by immunohistochemistry using
Vitreous Treatment of RPE Cells
Vitreous gel from human donor eyes was shredded by using a syringe, diluted with three volumes of complete medium and was vacuum-filtered through a 0.22-m polyethersulfone filter (Corning Inc., Corning, NY). 15 Control medium was also filtered. At the 0 time point, the medium was removed from subconfluent RPE cells and replaced with complete, serumcontaining medium or complete, serum-containing medium containing 25% vitreous. Both control and vitreous-treated cells were then incubated at 37°C for the same time (6, 12, 24, or 48 hours) before RNA extraction. Cells were still subconfluent at the time RNA was extracted.
RNA Extraction
The medium was quickly removed from the cells, which were briefly washed with PBS. RNA was extracted (RNeasy; Qiagen Inc., Valencia, CA). Column-bound RNA was treated with DNase (Qiagen, Inc.), according to the manufacturer's directions, except that the concentration and time for DNase treatment were doubled. The amount and purity of the total RNA were determined from the absorbance at 260 and 280 nm and by nondenaturing gel electrophoresis.
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RNA Amplification and Hybridization to Microarrays
RNA extracted from each of three low-passage RPE donor-vitreous donor pairs at 6, 12, 24, or 48 hours of control treatment or vitreous treatment was copied into cDNA and subjected to linear amplification using an aRNA amplification kit (Amino Allyl MessageAmp; Ambion Inc., Austin, TX). The amino allyl-labeled RNA was fluorescently labeled with cyanine-3 or -5 using reactive dye packs (CyDye PostLabeling; GE Healthcare, Piscataway, NJ) and purified on GFX columns (GE Healthcare). Fluorescently labeled RNA from the vitreous-treated and the corresponding control cells, each labeled with a different cyanine dye, were mixed and hybridized to prehybridized 70-mer oligonucleotide microarray slides (Operon Human Genome Oligo Set ver. 2, 21,318 genes; University of Cincinnati Genomics and Microarray Laboratory, Cincinnati, OH) according to the protocols of the W. M. Keck Foundation Biotechnology Resource Laboratory (New Haven, CT). All samples were analyzed twice, with the dyes reversed on the second analysis, giving a total of 24 dual-color microarray slides. Slides were scanned at the University of South Carolina Microarray Facility (ScanArray 5000; PerkinElmer Life and Analytical Sciences, Wellesley, MA) or the University of Cincinnati Genomics and Microarray Laboratory (GenePix 4000B; Molecular Devices, Sunnyvale, CA).
In all cases, RNA from vitreous-treated cells from a particular donor was compared with RNA from untreated cells from the same donor, which were grown at the same time and incubated for the same period after medium change. Thus, genes that varied in expression from donor to donor but which were not modulated by vitreous should not be detected using this approach.
Analysis of Gene Expression
Microarray analysis software (GeneSpring; Agilent Technologies, Palo Alto, CA) was used for the initial analysis of the digitized data and to correct for background. Gene expression was normalized using the Lowess option and the ratio of expression in vitreous:control cells determined for each gene (see Appendix A; all Appendices are online at http://www.iovs.org/cgi/content/full/48/4/1853/DC1). The resultant data were analyzed using the Significance Analysis of Microarrays (SAM) statistics program to determine genes that were significantly regulated at each time point. 17 SAM uses a permutation method to determine the significance of the results and hence reports a falsediscovery rate (FDR) rather than a probability. In addition, genes that gave signals at least 10 standard deviations above background (microarray scanner fluorescence values of Ͼ300 for ScanArray data [PerkinElmer] and Ͼ100 for GenePix data [Molecular Devices]) for both control and vitreous channels and that were regulated by at least twofold at any time point in all three donors were determined using the microarray analysis software (GeneSpring; Agilent Technologies). SOURCE 18 was used to annotate genes and to convert accession numbers to Entrez Gene IDs/Locus Link IDs or HGNC (Human Genome Nomenclature Committee) gene symbols. EASE 19 software was used to remove duplicated genes. Pathways were examined using the WebGestalt-Gene Set Analysis Toolkit 20 programs to search the KEGG database. 21 Statistical significance was determined using the hypergeometric test option. The Gene Ontology Database 22 was searched with DAVID 23 , EASE, Ontoexpress, 24 and GOTM.
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Reverse Transcription and Quantitative Real-Time PCR Total RNA (1 g) was reverse transcribed into cDNA (Iscript reagents; Bio-Rad Laboratories, Hercules, CA) and simultaneous priming from both oligo(dT) and random hexamers. The cDNA mix was diluted to 300 L with glass-distilled water. QPCR was performed (iQ SYBR Green Supermix; Bio-Rad Laboratories, Hercules, CA) with 5 L of the diluted DNA and 2.5 picomoles of each primer in a total volume of 25 L. Reactions were run on a PCR system (iCycler IQ Real Time PCR; Bio-Rad Laboratories). Primer pairs (Table 1) were designed on computer (Oligo 6; Molecular Biology Insights, Cascade, CO). The specificity of all primer pairs was 25 which corrects for any differences in the expression of the internal normalization gene (RPLP0; internal loading control) as well as for any differences in the efficiency of amplification for the primer pairs for each gene (Table 1) . Statistical significance was determined using REST-XL software. 26 Statistical analysis with this program in the non-normalized mode showed that vitreous treatment had no significant effect on the expression of the internal standard gene (RPLP0).
Immunohistochemistry
RPE cells were grown for 48 hours in control medium or medium containing 25% vitreous. To inhibit secretion of extracellular proteins, Brefeldin A (Sigma-Aldrich, St. Louis, MO) was then added to the medium to a final concentration of 5 ng/mL, and the incubation was continued for a further 6 hours. The cells were fixed in 4% paraformaldehyde, permeabilized with 0.5% Triton X-100, and stained with rabbit anti-human tissue plasminogen activator antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA) or with rabbit anti-human BMP-2 antibody (Aviva Systems Biology, San Diego, CA) followed by Cy5-conjugated anti-rabbit IgG (Invitrogen). The cells were double stained with Texas Red phalloidin (Invitrogen) to detect actin microfilaments and were observed by confocal microscopy (Meta500; Carl Zeiss Meditec, Inc., Dublin, CA). * The GenBank accession number used to design the oligomer on the microarray is given, followed by the HGNC symbol. In the case of THBS1, there were two clones on the array for this gene.
† The ratio of mRNA levels in vitreous and control cells determined from microarray expression data for RPE donors 1 to 3 after 6, 12, 24, or 48 hours of treatment. The data were analyzed with SAM; results found to be significant (FDR Ͻ 5%) are shown in bold.
‡ qPCR was used to determine the ratio of mRNA levels in vitreous and control cells for the additional RPE donors 4 to 6 (top, middle, and bottom lines, respectively, for each gene) after 6, 12, 24, or 48 hours of treatment. The data were analyzed using REST-XL; results found to be significant (P Ͻ 0.05) are shown in bold.
Immunoblot Analysis
The cells were extracted with ice-cold extraction buffer (1% NP40; SigmaAldrich) in 50 mM Tris-HCl (pH 8.0) containing 340 mM NaCl, 1 mM phenylmethylsulfonyl fluoride (PMSF), 50 mM NaF and protease cocktail inhibitor (20 L/mL; Pierce Biotechnology Inc., Rockford, IL). The extract was centrifuged and dissolved for SDS-polyacrylamide gel electrophoresis. After electrophoresis, the proteins were transferred to polyvinylidene difluoride (PVDF) membrane (Bio-Rad Laboratories) and protein-binding sites were blocked overnight with 5% nonfat dried milk in blocking buffer (20 mM Tris-HCl [pH 7.6], 0.8 M NaCl, and 0.1% Tween-20). Membranes were incubated overnight at 4°C with the appropriate primary antibody diluted in blocking buffer. The primary antibodies used were rabbit anti-human TFPI2 (kindly given by Walter Kisiel, Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM; diluted 1:1000), or rabbit anti-human BMP-2 antibody (diluted 1:100; Aviva Systems Biology). After the membrane was washed, it was incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG (GE Healthcare). Chemiluminescence was used for detection (West Pico Supersignal; Pierce Biotechnology, Inc.).
RESULTS
Genes Modulated by Vitreous Treatment
Treatment of low-passage human RPE cells in serum-containing medium with 25% vitreous results in reproducible morphologic changes within 48 hours, although changes can often be detected earlier. 12, 27 Hence, changes in gene expression were examined after 6, 12, 24, or 48 hours of incubation with normal or vitreous-containing medium. Some heterogeneity of response was expected because of biological variation between vitreous or RPE cells from different donors. Because the goal was to identify general responses to vitreous, microarray analysis was performed on three different RPE donor-vitreous donor pairs (RPE donors 1-3). In all cases, both control and vitreous-treated cells were kept subconfluent throughout treatment, partly because it is assumed that as RPE cells migrate into the vitreous, they are no longer in confluent monolayers and start to divide. 2, 4 In addition, this method avoids possible complications resulting from vitreous-treated cells' being less subject to contact inhibition than untreated cells. 12 Genes that gave microarray signals that were at least 10 SD above background and that also showed at least twofold changes in expression in all three microarray donors (RPE donors 1-3) at any time point were identified. These 200 genes are referred to as the twofold/donors 1 to 3 gene set. Thus, these were genes with mRNA that was readily detectable on arrays with reproducible changes in expression at a level that should be detectable by qPCR. However, such an analysis may miss many mRNAs with lower levels of expression for at least one donor, or those that were regulated by less than twofold in at least one donor. Therefore, the data were also analyzed with SAM statistical analysis. SAM takes into account not only the ratio of a gene's expression in treated compared with control cells, but also the variation in expression. It can thus detect changes in regulation of genes with expression levels or expression changes less than the cutoffs used for the twofold/ donors 1 to 3 gene set. Not surprisingly, SAM analysis at each time point using a false-discovery rate (FDR) of Ͻ5% detected many more regulated genes. The number of regulated genes increased at longer periods of vitreous treatment, consistent with a prolonged, progressive alteration in the gene transcription program ( Fig. 1; see Appendix B for the gene list). The 1335 regulated genes from the SAM FDR Ͻ 5% gene set included 187 of the 200 genes in the twofold/donors 1 to 3 gene set. Because these 187 genes were likely to be robustly regulated by vitreous in all donors at levels detectable by qPCR, we refer to this subset of the SAM FDR Ͻ 5% gene set as the "stringent gene set" (Appendix C). We focused on the stringent gene set for much of the initial validation. Most (79%) of the genes in this set were regulated at multiple time points, supporting the concept that these genes were robustly regulated by vitreous. A further indication of the reliability of the data was that 96% of those genes regulated at multiple time points were regulated at adjacent time points.
Validation of Changes in mRNA Expression
To test the reliability of the microarray analysis, the effect of vitreous-treatment on 10 of the vitreous-regulated genes was determined in three additional donor/vitreous pairs (RPE donors 4 -6) at 6, 12, 24, or 48 hours of treatment. Some genes were chosen because the changes observed on the microarrays were consistent with an EMT response. These included ␣-5 integrin (ITGA5), 28 Slug (SNAI2), 29 and collagen IV (COL4A1). 30 Connective tissue growth factor (CTGF) and thrombospondin-1 (THBS1) were included because others have speculated that increased expression of these genes, possibly by RPE cells, play a role in the early stages of PVR, 31, 32 but the microarrays showed decreased expression. The remaining five genes (SAT, TFPI2, tissue plasminogen activator [PLAT], ADAMTS5, and TFRC) were chosen arbitrarily because they were up-or downregulated at multiple time points. However, recent reports indicate that TFPI2 is an RPEspecific growth factor 33 and that SAT is involved in cell migration. 34 These genes were all in the stringent gene set, except for SNAI2 which was in the SAM FDR Ͻ 5% gene set only. The qPCR results confirmed the microarray data for all 10 genes (Table 2 ; compare the average of the microarray results for RPE donors 1-3 with the qPCR data for donors 4 -6) . In general, the kinetics of gene regulation was similar to the microarray analysis, although the response of RPE donor 6 tended to be more transient than that of donors 4 and 5.
We also examined expression of some of these genes at the protein level. We have reported that vitreous induces increased expression of ␣-5 integrin protein. 27 Expression of PLAT protein was examined by immunohistochemistry of RPE cells grown in the presence or absence of vitreous for 48 hours and then treated with 5 ng Brefeldin A/mL for 6 hours to prevent secretion of PLAT. Control cells showed little cytoplasmic fluorescence for PLAT ( Figs. 2A-C) . However, vitreous treatment caused increased levels of PLAT protein in virtually all cells (Figs. 2D-F) . Expression of TFPI-2 protein was examined by immunoblot analysis of extracts from cells grown in the presence or absence of vitreous and treated with 5 ng Brefeldin A/mL for the final 6 hours of treatment. TFPI-2 protein levels were increased in the vitreous-treated cells at both 24 and 48 hours (Fig. 3) .
Changes in mRNA levels for an additional eight genes from the SAM FDR Ͻ 5% list have been confirmed by qPCR (data not shown). Most attempts to confirm changes in mRNA expression of genes from this list have been successful. Failures were usually because of problems with design of good qPCR primers or because the signal in qPCR was too low.
We have reported that the mRNA and protein for three genes associated with inflammation, cyclooxygenase-2 (PTGS2), prostaglandin E synthase (PTGES), and heme-oxygenase 1 (HO1) are increased by vitreous 15, 35 ; all three genes * KEGG Genetic Information Processing, Environmental Information Processing, and Cell Processes pathways were analyzed by using WebGestalt. All pathways that were represented by more than two genes and found to be significantly (P Ͻ 0.050, hypergeometric test) overexpressed in the gene set of interest compared with all the genes on the microarray are shown. (-) P Ͼ 0.100. †P ϭ 0.050 -0.010.
were present in the SAM FDR Ͻ 5% gene set. We have reported that 48 hours of vitreous treatment results in decreased levels of fibroblast growth factor 2 (FGF2) mRNA and protein and that FGF2 downregulation plays an important role in the response to vitreous. 12, 27 FGF2 was downregulated at 48 hours on the arrays for donors 1 and 3 (ratio of vitreous to control 0.49 and 0.51, respectively) but not in donor 2 (ratio 1.25). Interpretation of the array data is complicated, because the arrays only detect the largest of the four forms of FGF2 mRNA found in RPE cells 36 and thus may give misleading results. Even if donor 2 failed to downregulate FGF2, it is likely that signaling via the FGF pathway decreased, since FGF1, FGF5, and fibroblast growth factor receptor-2 (FGFR2) were all significantly downregulated (SAM analysis, FDR Ͻ 5%). In addition, vitreous contains soluble FGFRs, which would sequester FGF2 37 
Pathway Analysis of Genes Modulated by Vitreous
The Genetic Information Processing, Environmental Information Processing and Cell Processes pathways from the KEGG database were analyzed with the WebGestalt program. Table 3 shows the results for all pathways identified as significantly (P Ͻ 0.05) overrepresented in the SAM FDR Ͻ 5% or the stringent subset of vitreous-modulated genes compared with the total gene set on the microarrays. Of the six pathways identified as the most significantly (P Ͻ 0.01) overrepresented in the stringent gene set, five (extracellular matrix-receptor interaction, focal adhesion, TGF-␤ signaling, cell communication, and hematopoietic cell lineage pathways) were also among the most significantly (P Ͻ 0.01) overrepresented in the SAM FDR Ͻ 5% gene list. Because epithelioid RPE cells in culture tend to stay associated with each other after cell division, whereas vitreous-treated cells tend to migrate away from each other, 27 the overrepresentation of genes associated with the focal adhesion pathway (Table 4) was of interest. The (Table 5 ) was also consistent with less close contact between cells. The overrepresentation of genes associated with the TGF␤/BMP pathway ( Table 6 , Fig. 4 ) was noteworthy because it has been proposed that TGF␤ plays an important role in PVR. 38 Table 6 includes six additional genes (RUNX2, POSTN1, DLX2, BAMBI, LAPTM5, and NBL1) from the SAM FDR Ͻ 5% gene set that are strongly associated with the TGF␤ and/or BMP pathways but that were not in the KEGG pathway gene list.
Effects of Vitreous on Expression of BMP-2 and Periostin mRNA
Because the potential involvement of the BMP-2 arm of the TGF␤/BMP-2 pathway (Fig. 4) was intriguing, mRNA levels for BMP-2 and periostin (a target of BMP-2 signaling, SAM [FDR Ͻ 5%] gene set) were measured by qPCR (Table 7) . Both were significantly upregulated by vitreous. Upregulation of periostin appeared to be later than that of BMP-2, as would be expected if it were a downstream target of BMP-2 signaling.
Immunohistochemistry and Immunoblot Analysis of BMP-2
To determine whether vitreous modulates the levels of BMP-2 protein, RPE cells were grown in the presence or absence of vitreous for 48 hours and then treated with 5 ng Brefeldin A/mL for 6 hours to prevent secretion of BMP-2. Cells were stained using anti-human BMP-2 antibody to detect intracellular BMP-2 and were also stained for F-actin so that the proportion Table 4 . (Figs. 5Ad-f ).
Immunoblot analysis indicated that treatment of the cells for 42 hours with vitreous followed by 6 hours with Brefeldin A resulted in the accumulation of a protein with an apparent molecular weight of ϳ42 kDa that bound anti-human BMP-2 antibodies (Fig. 5B ). This size of protein was consistent with the molecular weight of pro-BMP-2 (the expected form of BMP-2, since Brefeldin A should inhibit processing of pro-BMP-2).
DISCUSSION
Oligonucleotide microarray technology enables mRNA levels for many genes to be examined simultaneously. Changes in mRNA levels are often (although not always) a good indication of changes in the expression of the corresponding protein.
Thus, knowledge of global changes in mRNAs is valuable for our understanding of how cells respond to changes in their environment. In the present work, we examined the effects of vitreous treatment on low-passage human RPE cells, since this may help to elucidate early changes in gene expression in RPE cells in PVR. Biological variation is to be expected when cells from different donors are used. For example, variations in the repertoire of retinal gene expression between normal individuals have been reported. 39 Using differential display methodology, we observed that some vitreous-induced gene changes were dependent on a particular RPE donor or a particular vitreous donor, whereas other gene changes were common to multiple RPE and vitreous donors. 12 In the present study the use of multiple RPE donors and multiple vitreous donors served a filtering function enabling us to remove responses specific to a particular donor due to genetics, phenotypic changes, undetected disease processes, and medications. This may in part explain the high validation rate of independent RPE-vitreous donor combinations using qPCR.
The number of vitreous-modulated genes increased from 6 to 48 hours of vitreous treatment, indicative of a gradual and major reprogramming of cell functions. Some changes were consistent with an alteration from epithelial-like to more motile Footnote symbols are as described in Table 2 . (Table 5) . Keratins 18 (KRT18) and 20 (KRT20), typical of simple epithelia 40 and collagen IV (COL4A), a typical component of epithelial cell basement membranes, 41 were also downregulated. Integrin ␣5 (ITGA5) is typically upregulated during epithelial-mesenchymal transformation. 28 We have shown integrin ␣5 protein is increased by vitreous treatment, 27 and in this study we report that the mRNA was upregulated. Slug is a transcriptional repressor associated with EMT in development and cancer 29 and epithelial cell migration during wound healing. 42 Slug and integrin ␣5 both have antiapoptotic effects, 43, 44 and increased expression of such factors could promote survival of RPE cells after detachment from the basement membrane during the early stages of PVR. Downregulated genes with expression that is associated with the differentiated state of RPE cells included MITF (microphthalmia-associated transcription factor), which is associated with RPE development 45 ; ezrin (VIL2), which is important in the long apical RPE microvilli 1 ; and retinol dehydrogenase 5 (RDH5) which participates in the RPE visual cycle. 1 The TGF␤/BMP pathway was significantly overrepresented in the vitreous-modulated genes. TGF-␤ and BMP belong to the TGF␤ superfamily of growth factors, both have been implicated in EMT 46, 47 and both can induce Slug. 29 TGF-␤ is known to play an important role in wound-healing and fibrosis and it has been postulated that it plays a role in PVR. In a mouse model of PVR, signaling via SMAD3 (a downstream target of TGF␤) is necessary for PVR, for transdifferentiation of RPE cells and for RPE cell expression of the myofibroblast marker, smooth muscle actin. 48 Normal vitreous contains TGF␤2, and levels of this cytokine have been reported to be elevated in PVR. 49 -53 Hence, vitreous treatment may be expected to activate TGF-␤ signaling, and we have preliminary evidence that TGF-␤ signaling plays a role in vitreous-induced phenotypic changes in low-passage human RPE cells 35 (Parapuram S, Li L, Ganti R, Hunt RC, Hunt DM, unpublished data, 2004 -2006 . From the array data, it appeared that the TGF␤-dependent arm of the pathway might be downregulated at later times, since expression of mRNA for TGF␤2, the major form of TGF␤ made by RPE cells, 54 and its receptor TGF␤R1 was decreased at 12 to 48 and 24 to 48 hours, respectively. The decrease in throm- bospondin-1 (THBS1) and increase in latent TGF␤-binding protein (LTBP1) expression could result in less activation and more sequestration of TGF␤. 55 CTGF has been reported to be induced by TGF␤, to prolong TGF␤ signaling, and to be important in some of the profibrotic effects of TGF␤. 56 Thus, although downregulation of CTGF mRNA was unexpected in view of some of the models of the initial events in PVR, 31 this finding would fit with the concept of decreased TGF␤ signaling at later times in vitreous-treated RPE cells. In PVR, RPE cells can acquire myofibroblast-like properties, and TGF␤ and CTGF play important roles in myofibroblast differentiation, 56 which is associated with increased smooth muscle actin (ACTA2) expression. ACTA2 mRNA expression was decreased at later times, which would also be consistent with a downregulation of the TGF␤/CTGF pathway. Thus, although the vitreoustreated RPE cells have some features of fibroblasts, they may not be differentiating into myofibroblasts in this system, at least at the times examined. NRK fibroblasts treated with TGF␤ and CTGF do not differentiate into myofibroblasts if they are still proliferating 57 and our experiments were performed with subconfluent cells in the presence of serum. Thus, even if TGF␤ and CTGF were present and functional at early times, they may not be able to induce full myofibroblast differentiation in the subconfluent system. The fact that genes upregulated by vitreous did not include genes associated with fibrotic extracellular matrix production such as fibronectin or collagen I would be consistent with this. Thus, cultured, vitreous-treated RPE cells may be able to control fibrotic and myofibroblast responses induced by TGF␤ by downregulation of the TGF␤ pathway at later times, at least in subconfluent conditions. In vivo, additional factors, including variation between individuals in patterns of gene expression, 39 may interfere with this protective mechanism and contribute to the disease progression and fibrosis.
The array data were consistent with upregulation of the BMP-2 pathway. BMP-2 mRNA and protein were increased (Table 7 , Fig. 5 ), and the BMP pathway inhibitors BAMBI, NBL1 and smurf2 were downregulated. In addition, periostin, runx2, DLX2, and ID1 have all been reported to be targets of BMP-2 signaling 58 -60 and all were upregulated. Of interest, in view of the fact that ID1 can suppress myogenesis, 60 expression of genes related to muscle development was significantly downregulated in vitreous-treated cells. Although runx2, periostin, and ID1 are typically BMP targets, they can also be targets of the TGF␤ pathway. [61] [62] [63] There is cross-talk between the TGF␤ and BMP pathways, 64 and a balance between these pathways may be important in the effects of vitreous on RPE cells.
Our results show that many of the effects of vitreous treatment on gene expression by RPE cells are consistent with what might be expected in early PVR. These include major changes in gene expression, upregulation of genes associated with stress and inflammation, downregulation of genes associated with epithelial cells and upregulation of genes associated with migration. The TGF␤ pathway has already been implicated in PVR, but from the array data, it is possible that signaling via other members of the TGF␤ family such as BMP-2 may also be important.
